SUTRO BIOPHARMA, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $394.1M
Liabilities Breakdown FY2020
Total Liabilities: $62.1M
Asset Breakdown
Total Assets: $394.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $206.2M | 52.3% |
| Accounts Receivable | $5.6M | 1.4% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $12.9M | 3.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $169.5M | 43.0% |
Liabilities Breakdown
Total Liabilities: $62.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.5M | 8.9% |
| Long-Term Debt | $24.5M | 39.5% |
| Other Liabilities | $32.0M | 51.5% |